Biotech Business - October 29, 2021
Abera enters collaboration with American university
Abera Bioscience initiates collaboration with an American university to accelerate the development of a vaccine candidate based on the company’s latest vaccine platform comprising protein bodies. The study will be conducted in vivo and will provide a first indication of applicability outside of the pneumococcal area. The cost profile for protein body-based vaccine formulations is […]
COVID-19 - September 16, 2021
Vaccine based on Abera’s technology shows neutralizing antibodies against Delta version
The vaccine platform developed by Abera Bioscience has been used in a collaboration between researchers at Johns Hopkins University School of Medicine (Baltimore, USA) and Vrije Universiteit (Amsterdam, the Netherlands) to produce and test a novel, nasal SARS-CoV-2 vaccine candidate. Previously published data have now been supplemented with further analyses showing that the vaccine candidate […]
COVID-19 - August 6, 2021
Vaccine based on Abera’s technology shows good results
The vaccine platform developed by Abera Bioscience has been used in a collaboration between researchers at Johns Hopkins University School of Medicine and Vrije Universiteit to produce and test a novel SARS-CoV-2 vaccine candidate. The results from a study in a golden hamster infection model were published earlier this summer, showing that the vaccine candidate […]
